MicroRNA Childhood Cancer Catalog (M3Cs)

Publication Title	DOI	Year
PCAF regulates H3 phosphorylation and promotes autophagy in osteosarcoma cells	https://doi.org/10.1016/j.biopha.2019.109395	2019	Cell line 3 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
lncRNA C2dat1 Promotes Cell Proliferation, Migration, and Invasion by Targeting miR-34a-5p in Osteosarcoma Cells	https://doi.org/10.3727/096504017X15024946480113	2018	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
CCL3 promotes angiogenesis by dysregulation of miR-374b/ VEGF-A axis in human osteosarcoma cells	https://doi.org/10.18632/oncotarget.6708	2016	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Microarray Expression Profile and Functional Analysis of Circular RNAs in Osteosarcoma	https://doi.org/10.1159/000481650	2017	Cell line 20 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-338-3p inhibits tumor growth and metastasis in osteosarcoma cells by targeting RUNX2/CDK4 and inhibition of MAPK pathway	https://doi.org/10.1002/jcb.27929	2019	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-300 decreases cell viability, inhibits migration and promotes apoptosis of osteosarcoma cells via downregulation of Twist1	https://doi.org/10.3892/mmr.2017.7023	2017	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Co-targeting of DNA, RNA, and protein molecules provides optimal outcomes for treating osteosarcoma and pulmonary metastasis in spontaneous and experimental metastasis mouse models	https://doi.org/10.18632/oncotarget.16372	2017	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-126 enhances the sensitivity of osteosarcoma cells to cisplatin and methotrexate	https://doi.org/10.3892/ol.2015.3790	2015	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Identification of miR-200c-3p as a major regulator of SaoS2 cells activation induced by fluoride	https://doi.org/10.1016/j.chemosphere.2018.01.095	2018	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
microRNA-mediated differential expression of TRMU, GTPBP3 and MTO1 in cell models of mitochondrial-DNA diseases	https://doi.org/10.1038/s41598-017-06553-w	2017	Cell line 5 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Extracellular Nanovesicles Secreted by Human Osteosarcoma Cells Promote Angiogenesis	https://doi.org/10.3390/cancers11060779	2019	Cell line 8 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
HSP90 regulates osteosarcoma cell apoptosis by targeting the p53/TCF-1-mediated transcriptional network	https://doi.org/10.1002/jcp.29283	2019	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Combinatorial treatment of DNA and chromatin-modifying drugs cause cell death in human and canine osteosarcoma cell lines	https://doi.org/10.1371/journal.pone.0043720	2012	Cell line 18 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
A genome landscape of SRSF3-regulated splicing events and gene expression in human osteosarcoma U2OS cells	https://doi.org/10.1093/nar/gkv1500	2016	Cell line 9 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-650 in a copy number-variable region regulates the production of interleukin 6 in human osteosarcoma cells	https://doi.org/10.3892/ol.2015.3581	2015	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Identification of DNA-PKcs as a primary resistance factor of salinomycin in osteosarcoma cells	https://doi.org/10.18632/oncotarget.12712	2016	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Consensus micro RNAs governing the switch of dormant tumors to the fast-growing angiogenic phenotype	https://doi.org/10.1371/journal.pone.0044001	2012	Cell line 3 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-30a downregulation contributes to chemoresistance of osteosarcoma cells through activating Beclin-1-mediated autophagy	https://doi.org/10.3892/or.2015.4497	2016	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-135b promotes proliferation, invasion and migration of osteosarcoma cells by degrading myocardin	https://doi.org/10.3892/ijo.2014.2641	2014	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-148a Acts as a Tumor Suppressor in Osteosarcoma via Targeting Rho-Associated Coiled-Coil Kinase	https://doi.org/10.3727/096504017X14850134190255	2017	Cell line 3 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View

Publications